July 29 (SeeNews) - North Macedonia-based drug maker Alkaloid [MSE:ALK] said on Thursday that its consolidated net profit grew by an annual 14% in the first half of 2021, reaching 583.6 million denars ($11.2 million/9.4 million euro).
Sales revenue edged up 3.4% year-on-year to 6.3 billion denars in the January-June period, Alkaloid said in an interim financial statement filed with the Skopje bourse.
Domestic sales increased by 7.3% to 2.2 billion denars, while sales abroad added 1.4% to 4.1 billion denars.
The cost of goods sold was 2.4% higher on the year at 3.4 billion denars in the review period.
The company's shares traded at an average price of 15,747 denars on Wednesday, bourse data showed.
Alkaloid has two subsidiaries in North Macedonia and 18 subsidiaries and two representative offices abroad - in Serbia, Montenegro, Kosovo, Albania, Bosnia and Herzegovina, Croatia, Slovenia, Switzerland, Bulgaria, Turkey, Ukraine, Russia, the U.S. and the UK.
The company employs 1,860 people in North Macedonia and 560 in its subsidiaries outside the country.
(1 euro = 61.90 denars)